Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

Completed

Conditions studied: Glaucoma

In brief

A retrospective, non-interventional, observational, multi-center, chart review study to be conducted in participants who underwent placement of the XEN 45 Gel Stent as a standalone procedure or in combination with phacoemulsification from 1 January 2014 to 1 October 2015.

Key facts

Study ID

NCT03868254

Run by

Allergan

People needed

174

Starts

2019-04-05

Expected to finish

2019-10-25

Last updated by the study team

2020-11-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eye treated with XEN 45 Gel Stent for primary open angle glaucoma as a standalone procedure or in combination with phacoemulsification
• XEN 45 Gel Stent was implanted between 1 January 2014 and 1 October 2015

You may not qualify if…

• None

Where it is running

• Clinical Trials Registry Team — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.